US14070B3096 - Common Stock
CAPRICOR THERAPEUTICS INC
NASDAQ:CAPR (9/24/2024, 4:19:10 PM)
After market: 8.92 -0.18 (-1.98%)9.1
+3.13 (+52.43%)
Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of biological therapies for the treatment of cardiac and other serious medical conditions. The company is headquartered in Beverly Hills, California and currently employs 101 full-time employees. The company went IPO on 2002-06-04. The firm's program is focused on the development and commercialization of a cell therapy technology comprised of cardiosphere-derived cells (CDCs) for the treatment of Duchenne muscular dystrophy (DMD). Its lead product candidate, CAP-1002, is an allogeneic cardiac-derived cell therapy. CAP-1002 is advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy (DMD). CAP-1002 demonstrates immunomodulatory, antifibrotic, and regenerative actions specifically tailored for dystrophinopathies and heart disease. The firm leverages its exosome technology, using its StealthX platform in preclinical development focused on the areas of vaccinology, targeted delivery of oligonucleotides, proteins and small molecule therapeutics to potentially treat and prevent a diverse array of diseases.
CAPRICOR THERAPEUTICS INC
8840 Wilshire Blvd, 2nd Floor
Beverly Hills CALIFORNIA 90211
P: 13103583200
CEO: Linda Marban
Employees: 101
Website: https://capricor.com/
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
Which stocks are moving on Tuesday?
Which stocks are gapping on Tuesday?
Investor Webcast on Tuesday, September 24, 2024 at 8:30 a.m. ET...
-Capricor to Receive $15 Million Equity Investment at a 20% Premium, as well as $20 Million Upfront Payment upon Signing Definitive Agreement with up to...
SAN DIEGO, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and...
Here you can normally see the latest stock twits on CAPR, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: